In This Issue: Drug Topics May 2024

News
Slideshow

See what's trending in pharmacy with a preview of the Drug Topics May issue.

With stories on sun protection and skin care in the digital era, the May 2024 issue of Drug Topics highlights skin health. It also tackles pressing public health issues, including the rise in measles cases, ongoing research into long COVID, and challenges surrounding vaccine access. Find other key stories here.

To read these stories and more, download the PDF of the Drug Topics May 2024 issue here.

Recent Videos
Related Content
Evaluating Empagliflozin’s Impact on Cardiovascular Outcomes in Patients with T2D | AHA 2024

Evaluating Empagliflozin’s Impact on Cardiovascular Outcomes in Patients with T2D | AHA 2024

Killian Meara
November 20th 2024
Article

Two posted presented at the American Heart Association’s 2024 Scientific Sessions explored empagliflozin among patients with type 2 diabetes and cardiovascular risk.

FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?

FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?

Brian Nowosielski
October 31st 2024
Podcast

Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.

Real-Time Pharmacist Feedback Improves Heart Failure Medication Management | AHA 2024

Real-Time Pharmacist Feedback Improves Heart Failure Medication Management | AHA 2024

Lauren Biscaldi, MS, Managing Editor
November 20th 2024
Article

Results of a study at the Veterans Health Administration found that feedback and education led to better medication outcomes for patients.

Keeping the Focus on Community Pharmacy Advocacy at the State Level

Keeping the Focus on Community Pharmacy Advocacy at the State Level

Brian Nowosielski
September 23rd 2024
Podcast

Drug Topics discussed independent pharmacy advocacy and PBM reform on the state level with Miguel Rodriguez, Executive Vice President and general counsel for American Pharmacies.

Eating Problems, Diabetes Distress Associated with Worse Time-in-Range | AHA 2024

Eating Problems, Diabetes Distress Associated with Worse Time-in-Range | AHA 2024

Killian Meara
November 19th 2024
Article

Patients with type 2 diabetes who had eating problems and higher levels of diabetes distress had worse time-in-range.

Over Half of US Population Concerned About Prescription Drug Access, Prices

Over Half of US Population Concerned About Prescription Drug Access, Prices

Brian Nowosielski
November 19th 2024
Article

Wolters Kluwer Health conducted a survey of just over 1000 respondents to get US adults’ feelings about notable trends in the pharmacy industry.

© 2024 MJH Life Sciences

All rights reserved.